Liquid Biopsy for Early Cancer Detection

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

301 papers

Showing 109-120 of total 301 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Cell-Free DNA Release Kinetics and Fragmentation Reflect Treatment Response and Resistance In Vitro.

Bartolomucci A; Kienzle L; Ferrier ST; Forgie B; Tsering T; Dickinson K; Ferri L; Cools-Lartigue J; Burnier JV

2026PubMedSupporting evidence

Non-Invasive Assessment of Microvascular Invasion Risk in Hepatocellular Carcinoma Using Liquid Biopsy: Translational Insights and Clinical Implications.

Xue D; Gao X; Zhang Q; Li H; Chen M; Duan X; Wang X; Yu P; Tao Z; Cheng X

Jan 1, 2026Diagnostics (Basel, Switzerland)

2026PubMedDirectly related

Premature immunosenescence in AYA gastrointestinal cancer: The metabolic-inflammatory-hormonal axis as an integrative framework: A systematic review.

Wen J; Yu H

Jan 1, 2026Medicine international

2026PubMedDirectly related

Liquid Biopsy and Nonendoscopic Biomarkers for Precision Early Detection of Esophageal Cancer: Evidence, Risk Stratification and Translational Challenges.

Han F; Liu H

Jan 1, 2026Journal of Cancer

2026PubMedDirectly related

Clonal evolution in gastrointestinal cancers: multi-omics insights into tumor heterogeneity, microenvironmental selection, and translational biomarkers.

Fan W; Zheng C

Jan 1, 2026Frontiers in oncology

2026PubMedDirectly related

Clinical value of blood circulating tumor RNA (ctRNA) in liquid biopsy of lung cancer: a narrative review.

Zhu L; Xian L; Zhou L; Yi M; Li J; Liu Y; Ma S; Liu L

Jan 1, 2026Translational lung cancer research

2026PubMedDirectly related

Combining Napsin A expression with circulating tumor cell counts for enhanced identification of pulmonary adenocarcinoma in ground-glass nodules.

Ruan S; Yu H; Song Z; Zhu X; Yuan G; Xie H; Zhang C; Wei T

Jan 1, 2026Translational cancer research

2026PubMedDirectly related

Beyond traditional biopsy: integrating liquid biopsy, molecular panels, and advanced imaging techniques in thyroid cancer management.

Eren A; Karatay E

Jan 1, 2026Endokrynologia Polska

2026PubMedDirectly related

Identification of a G-quadruplex-forming cell-free DNA fragment as a biomarker for the precise diagnosis of hepatocellular carcinoma.

Sun J; Teng X; Zhang W; Dai Y; Liu L; Li J

Jan 1, 2026Chemical science

2026PubMedDirectly related

Urinary miR-574-5p as a candidate biomarker for early-stage lung adenocarcinoma: an exploratory case-control study.

Nagashima R; Aragaki M; Hatanaka KC; Shinomiya Y; Ushijima M; Fujiwara-Kuroda A; Ohtaka K; Shiiya H; Chiba R; Otsuka S; Nakaya T; Omine R; Kuji T; Hatanaka Y; Kato T

Jan 1, 2026Translational lung cancer research

2026PubMedDirectly related

Non-small cell lung cancer and tumor-educated platelets: screening of biomarkers and construction of a prognostic model.

Zhao Y; Tang T; Li J; Chen L; Gu X; Li Q

Jan 1, 2026Translational cancer research

2026PubMedDirectly related

Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation.

Bazan Russo TD; Gristina V; Delcuratolo MD; Tamburi L; Delli Muti F; Mangiacotti F; Mujacic C; Fanale D; Galvano A; Gori S; Incorvaia L; Giordano A; Pepe F; Malapelle U; Russo A; Muscarella LA; Fabrizio FP

Jan 1, 2026Frontiers in oncology